ZENECA ZESTRIL BRAND LISINOPRIL OUTSELLING MERCK'S PRINIVIL TWO TO ONE, ZENECA REPORTS; PHARMACEUTICAL SALES IN U.S. DECLINE 2% FROM 1993
Executive Summary
Zeneca's Zestril brand of lisinopril is outselling Merck's Prinivil two to one, according to January IMS data, Zeneca Pharmaceuticals President Robert Black said at a press conference March 2 in New York City. Two of every three lisinopril prescriptions were filled with Zestril in January, Black reported. The Zeneca drug's U.S. market share rose from 17.9% to 19%, he added. Zeneca licenses lisinopril from Merck.